JB THERAPEUTICS
JB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation. It has also completed a Phase II clinical study in chronic refractory neuropathic pain. JBT-101 is currently being developed as a potential disease modifying treatment for osteoarthritis. JBT-101 also represents a platform for combination with other anti-inflammatory and analgesic agents as well as various drug delivery strategies including ointment and gels, topical patches, and timed release formulations.
JB THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Newton Center, Massachusetts, United States
Country:
United States
Website Url:
http://www.jbtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
1-617-413-3020
Email Addresses:
[email protected]
Total Funding:
687 K USD
Technology used in webpage:
Nginx Energy Group Hosting
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Certa Therapeutics
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
ImmunSYS
ImmunSYS is a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products.
JeniVision
JeniVision, are an innovative biopharmaceutical company that strives to discover advanced therapies for eye and skin diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Myosin Therapeutics
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Trophos
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology
TSG Therapeutics
TSG Therapeutics is a preclinical-stage biopharmaceutical firm dedicated to the abolition of viral infectious illness.
Viron, Inc.
Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Current Employees Featured
Founder
Investors List
Maine Angels
Maine Angels investment in Seed Round - JB Therapeutics
Maine Angels
Maine Angels investment in Venture Round - JB Therapeutics
Boston Harbor Angels
Boston Harbor Angels investment in Angel Round - JB Therapeutics
Official Site Inspections
http://www.jbtherapeutics.com
- Host name: 104.247.81.99
- IP address: 104.247.81.99
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "JB Therapeutics"
JB Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View JB Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
JB Therapeutics - Crunchbase Company Profile & Funding
JB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 …See details»
上海药明巨诺生物科技有限公司
药明巨诺（港交所代码：2126）是一家独立的、创新型的生物科技公司，专注于研发、生产及商业化细胞免疫治疗产品，并致力于以创新为先导，成为细胞免疫治疗引领者。创建于2016年， …See details»
上海药明巨诺生物科技有限公司 - JW Therapeutics
JW Therapeutics (HKEX: 2126) is an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, and is committed to becoming an innovation leader …See details»
Jw Company Profile | Management and Employees List - Datanyze
[email protected]: Your Questions, Our Answers Get Free Access to Jw Contacts Info. What is Jw revenue? Jw revenue is $23.3 M. How many employees does Jw have? Jw has …See details»
JW Therapeutics 药明巨诺 - LinkedIn
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough cell-based ...See details»
JB Therapeutics - Contacts, Employees, Board Members
JB Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies for orphan inflammatory diseases.See details»
JW Therapeutics - Crunchbase Company Profile
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses …See details»
JW Therapeutics (Shanghai) Co., Ltd.
了解JW Therapeutics (Shanghai) Co., Ltd. (上海药明巨诺生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验, 11篇新闻和2篇文献，疾病领域:肿瘤，免疫系统疾 …See details»
JW Therapeutics (Suzhou) Co., Ltd.
May 1, 2023 了解JW Therapeutics (Suzhou) Co., Ltd. (苏州药明巨诺生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 3篇新闻，疾病领域:肿瘤，免疫系统疾 …See details»
Presentation - JW Therapeutics
3 JW Therapeutics 2024 Business Review R＆D Progress As of December 31, 2024, Carteyva® has been listed in more than 80 commercial insurance products and 102 local governmental …See details»
JB Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 508 Dudley Road Suite 100. Newton, Massachusetts, 02459, United States. 617-413-3020See details»
Jw - Overview, News & Similar companies | ZoomInfo.com
Jw contact info: Phone number: +86 2150783699 Website: www.jwtherapeutics.com What does Jw do? JW Therapeutics (HKEx: 2126) is an independent and innovative biotechnology …See details»
JB Therapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for JB Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
JB Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2014: Seed Round - JB …See details»
细胞免疫疗法领军企业药明巨诺在港交所主板上市-美通社PR-News…
Nov 3, 2020 “在香港上市是药明巨诺非常重要的里程碑。”药明巨诺联合创始人、董事长兼首席执行官李怡平医生表示，“药明巨诺成立的初衷是通过突破性细胞疗法的开发，改变中国癌症患 …See details»
上海药明巨诺生物科技有限公司_投融资最新情况_摩熵医药 (原药融 …
药明巨诺是国内首个获得以CD19为靶点的CAR-T细胞（chimeric antigen receptor T cell，嵌合抗原受体 T 细胞）治疗产品的IND临床批件的企业，领跑中国CAR-T临床研究。目前，全球范围 …See details»
药明巨诺与2seventy bio宣布达成战略合作，加速T细胞免疫治疗的 …
药明巨诺致力于以突破性、高品质的细胞免疫治疗产品给中国乃至全球患者带来治愈的希望，并引领中国细胞免疫治疗产业的健康规范发展。欲了解更多详情，请访 …See details»
JW Therapeutics Announces its Cell Immunotherapy Drugs Have ...
SHANGHAI, Nov. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and …See details»
JB Laboratories 2025 Company Profile: Valuation, Investors
JB Laboratories General Information Description. Manufacturer of over-the-counter drugs. The company's over-the-counter drugs includes powders, capsules, tablets, multi-vitamins, cough …See details»